Washington, D.C. — A group of Senate Democrats is pushing to dismantle one of the federal government’s most controversial Medicare experiments, and the fight could reshape how prior authorization plays out in skilled nursing facilities for years to come.
Sens. Ron Wyden of Oregon, Maria Cantwell of Washington, Richard Blumenthal of Connecticut, and Kirsten Gillibrand of New York filed a resolution on Wednesday to roll back the Wasteful and Inappropriate Service Reduction model, better known as WISeR. Twenty senators have signed on so far, according to industry reports.
The model, launched earlier this year in six states, lets the federal government contract with private companies to apply artificial intelligence-backed prior authorization to certain Medicare services. CMS framed the program as a way to crack down on fraud and wasteful spending. Critics call it something else — a back door for AI to start denying care to seniors who already have a hard enough time getting it.
Why nursing homes should be paying attention
WISeR’s current target list is narrow on paper. It covers services like skin and tissue substitutes and epidural steroid injections for pain management. But those aren’t abstract categories. Skin substitutes are commonly used in wound care for residents with pressure injuries and diabetic ulcers. Epidural steroid injections are routinely ordered for older adults with chronic spine pain. Both populations live, in significant numbers, inside skilled nursing facilities.
Prior authorization is rare in traditional Medicare, which is precisely why the model has rattled providers. Long-term care operators have spent years complaining that the prior authorization paper chase in Medicare Advantage already siphons off staff hours that could go toward resident care. The idea of a similar model spreading into traditional Medicare struck a nerve.
“Americans are sick and tired of abusive prior authorization tactics putting needed health care out of reach,” Wyden said in a statement. “The last thing seniors need is even more AI denying the care they need.”
How the rollback works
The lawmakers are using the Congressional Review Act, a tool Congress can use to overturn agency rules. The Government Accountability Office concluded last week that WISeR qualifies as agency rulemaking, even though HHS argued the model was simply a guidance document. That decision opened a 60-day window in which Congress can force a vote.
House Democrats already tried this last year with a bill to repeal WISeR outright. It went nowhere. A separate report from Cantwell in April found that procedures subject to prior authorization in Washington state were taking weeks longer to clear, adding red tape for both patients and providers.
For nursing homes, the resolution is less about whether WISeR survives and more about what comes next. CMS has signaled appetite for AI-driven oversight, and federal officials are testing where the public’s tolerance ends. If the Senate manages to kill WISeR, it could slow that momentum. If it doesn’t, operators may want to start preparing for prior authorization rules that look a lot more like the ones their Medicare Advantage contracts already saddle them with.
Either way, the message coming out of the Capitol this week is unmistakable. AI in Medicare has officially become a political fight.
